Olpasiran leads to significant and sustained reduction in OxPL on apolipoprotein B
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors
Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even for Those With HTN, GDM
Although screening rates are higher for exposed individuals, rates are low in both exposed and unexposed individuals
Systolic BP Target <120 mm Hg Favored for Most Participants in BP Intervention Trial
Almost all older adults in SPRINT trial have predicted net benefit favoring systolic BP target <120 mm Hg versus <140 mm Hg
Sisters of Those With Adverse Pregnancy Outcome Also Have Increased CVD Risk
Women with APO and their APO-free sisters both have increased risks relative to unrelated APO-free comparators